Sign in: Staff/Students
Researchers at the University of Liverpool have shown Americans are paying significantly more for cancer drugs than their European counterparts.
Presented at the European Cancer Congress this week, the report focuses on analysis of the cost of tyrosine kinase inhibitors (TKIs), a potent class of cancer pills with fewer side effects than chemotherapy.
Dr Andrew Hill, Senior Visiting Research Fellow in the University’s Department of Pharmacology, found that pharmaceutical companies were charging up to 600 times what the medicines cost to make, with Americans paying double the price charged in Europe.
Based on Dr Hill’s findings, the World Health Organization (WHO), determined that the drugs can be made at lower cost.
Dr Hill said: “Several widely-used TKIs are expected to become available as generics within the next five years, as current patents expire. Large scale production could drastically reduce the annual cost of these drugs for patients.
“There has to be some middle ground between the prices that companies are charging, which may not even be cost-effective by the standards set by some healthcare authorities, and the actual production cost.
“The future pricing of TKIs could also have major implications for developing countries since mass production could open the way to widespread cancer treatment in the same way that cheap generic drugs helped fight HIV/AIDS.”
Lower death rate
The work follows on from Dr Hill’s research into the Hepatitis B drug, entecavir, which he found could be mass produced for only £24 ($36) per person per year versus the current UK NHS price of approximately £4,600, and the US price of over $15,000. This would lead to huge reductions in the number of people being infected with the disease and significantly lowering the current death rate of 686,000 per year worldwide.
The European Cancer Congress takes place in Vienna this month (Friday, 25 – Tuesday, 29 September 2015).
You must be logged in to post a comment.
All recent news
Liverpool technician wins prestigious Times Higher Education Award
Episode 28: Revisiting resilience: Chronicity and the four pillars of resilience
How to get a COVID-19 test before you travel
New research helps detect change in Arctic Ecosystems
Claim your graduation package
Confused about the rules of England's new #COVID19 tier system? Prof Tom Solomon @runningmadprof and @BBCHughPym helped answer listeners' questions (and there were many!) on @BBCr4today #LivUniCovid
📻 Listen from 2hr 36mins https://www.bbc.co.uk/sounds/play/m000pt9x
"It is gratifying to see technicians being recognised for the work that we do and I hope that my win will inspire others to realise that they can make a difference too.”
Congratulations again to John Waters on his amazing #THEAwards win👏
Full story ➡️ https://bit.ly/36eL7Dw
//VIDEO// ‘Human Chain: Poets on the Poetry of Seamus Heaney’
Bernard O’Donoghue @wadhamoxford, @Gail_McConnell_, @seanehewitt, Tara Bergin @StudentsNCL + Yousif M. Qasmiyeh @RefugeeHosts discuss Heaney + special reading by Bríd Brennan: https://news.liverpool.ac.uk/2020/11/27/institute-of-irish-studies-to-host-human-chain-poets-on-the-poetry-of-seamus-heaney/